Published in Blood Cells on January 01, 1994
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Umbilical cord blood banking: an update. J Assist Reprod Genet (2011) 1.06
The Royan Public Umbilical Cord Blood Bank: Does It Cover All Ethnic Groups in Iran Based on HLA Diversity? Transfus Med Hemother (2014) 0.75
Collection, Separation, Enumeration and Cryopreservation of Umbilical Cord Blood Haematopoietic Stem Cells - An Experimental Study. Med J Armed Forces India (2011) 0.75
Commentary: cord blood banking for bone marrow reconstitution: a need for standardization and international cooperation. Blood Cells (1994) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med (1980) 9.34
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Histological Localization of Newly-formed Desoxyribonucleic Acid. Science (1948) 6.56
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 6.49
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med (1987) 5.57
Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med (1975) 5.49
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Occupational risk for hepatitis C virus infection among New York City dentists. Lancet (1992) 3.31
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet (1997) 3.12
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
Delayed childbearing and the outcome of pregnancy. N Engl J Med (1990) 3.05
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
From twin to singleton. BMJ (1996) 2.79
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology (1982) 2.74
Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens (1998) 2.65
Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet (2000) 2.64
Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry (1994) 2.54
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Persistence of the serum hepatitis (SH-Australia) antigen for many years. Nature (1969) 2.37
Fortification of sugar with iron sodium ethylenediaminotetraacetate (FeNaEDTA) improves iron status in semirural Guatemalan populations. Am J Clin Nutr (1995) 2.32
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 2.22
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med (1995) 2.18
A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem (1991) 2.13
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Pregnancy outcome at age 40 and older. Obstet Gynecol (1996) 2.09
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol (1979) 2.06
Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 2.06
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Hepatitis B virus contains pre-S gene-encoded domains. Nature (1985) 2.02
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
First-trimester screening for aneuploidy: research or standard of care? Am J Obstet Gynecol (2000) 2.00
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med (1984) 1.93
Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA (1986) 1.90
Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med (1989) 1.90
Characterization of Soybean Plasma Membrane during Development: FREE STEROL COMPOSITION AND CONCANAVALIN A BINDING STUDIES. Plant Physiol (1980) 1.90
Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: analysis of 71 patients. Am J Cardiol (1983) 1.89
International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Investig (1996) 1.87
Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. Nature (1985) 1.87
Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med (1982) 1.87
Risk factors for severe preeclampsia. Obstet Gynecol (1994) 1.87
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
The Onchocerciasis Elimination Program for the Americas: a history of partnership. Rev Panam Salud Publica (1998) 1.79
Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
Are women who are Jehovah's Witnesses at risk of maternal death? Am J Obstet Gynecol (2001) 1.65
Anemia of end-stage renal disease (ESRD). Kidney Int (1985) 1.63
Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol (1991) 1.62
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol (1992) 1.61
The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol (1995) 1.61
Ultrasound in the diagnosis of congenital anomalies. Am J Obstet Gynecol (1979) 1.59
Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet (1975) 1.59
Change points in the series of T4 counts prior to AIDS. Biometrics (1995) 1.58
Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med (1986) 1.57
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis (1990) 1.57
Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA (1990) 1.55
Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol (1988) 1.54
Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis (1984) 1.53
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis (2001) 1.53